Presenting the All New Automation/Pharmacovigilance Knowledge Hub
ArisGlobal has created an Automation in Pharmacovigilance Knowledge Hub to help explain, in easily digestible terms, everything you need to know about automation in PV.
ArisGlobal has created an Automation in Pharmacovigilance Knowledge Hub to help explain, in easily digestible terms, everything you need to know about automation in PV.
Many life sciences companies are still utilizing a manual process for their medical affairs needs. ArisGlobal’s LifeSphere ® Medical Affairs platform can help automate this process. Learn more about Medical Affairs and automated processes with our webinar, Optimizing Adverse Event Reconciliation in Medical Affairs.
This is the fourth in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety business units at ArisGlobal. Director of Product Management – Medical Affairs and Quality, Sandeep Mahagaonkar, spoke about what attracted him to ArisGlobal, the state of Medical Affairs, and the vision for 2020 and beyond.
This is the first in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety product domains at ArisGlobal. Senior Director of Clinical Product Management, Sondra Pepe, describes what attracted her to ArisGlobal and articulated the vision for Clinical product strategy.
A large multinational medical device and health care organization embraces ArisGlobal’s LifeSphere LitPro to effectively automate all steps in the medical literature monitoring process.
In the last of our three-part blog series, we share the poll results to the question "What concerns do you have when it comes to automating PV process?" and analyze the responses. Read the blog to see how your responses might compare.
ArisGlobal believes that there is no single “right place to start” when it comes to automation, and life sciences organizations must instead choose their own adventure when it comes to a sound PV-focused automation strategy. Read part two of our three-part blog series.
During our recent webinar, when polled 43% of the audience said automating PV processes was one of their top strategic priorities, while 13% have no automation plan in place. That and other interesting insights are shared in this first of a three-part blog series.
Moving to a structured content authoring approach presents the challenge of ensuring that data and documents are in sync. So where do life sciences organizations stand today in this transformation phase? Wim Cypers, Senior VP, Regulatory, shares his insights from our recent webinar.
By 2020, 67% of physicians will be digital natives and will prefer obtaining medical information on specific medications through digital channels, and by 2025, 75% of our global workforce will be accomplished by millennials who are extremely comfortable with digital technology. In this final blog of our two-part series, we share how the move to self-service is creating a clear paradigm shift and impacting the content management strategy of today’s MI departments.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved